**Core tip:** Although the number of liver transplants done for alcoholic liver disease (ALD) has been stable been 2002 and 2012, since 2013 there has been a significant increase. This increase is seen across all age groups, although the proportional increases are higher for younger patients than older ones. The increase corresponds, but is incompletely explained, by a decrease in transplants for hepatitis C - ALD dual listing. The increase was also seen in most, but not all UNOS regions.

INTRODUCTION
============

Liver transplantation (LT) has become a life-saving procedure for patients with irreversible liver diseases. A total of 7841 liver transplants were performed in 2016 in the United States with 14389 potential recipients on the waiting list\[[@B1]\]. One of the common causes of chronic liver disease for which LT is potentially life saving is alcoholic liver disease (ALD). Progression of ALD is dependent on patient characteristics (sex, race, ethnicity, malnutrition), genetic factors, coexisting liver pathology \[*e.g*., hepatitis C virus (HCV) or non-alcoholic steatohepatitis (NASH)\] as well as drinking patterns (volume consumed, drinking outside meal times, binge drinking, and duration of consumption). The risk of developing cirrhosis is increased with consumption of \> 60-80 g/d of alcohol for ≥ 10 years for men and \> 20-40 g/d in women\[[@B2],[@B3]\]. However, despite drinking at these levels, only 6%-41% of people develop cirrhosis\[[@B2],[@B4]\].

Population-based studies have shown that although the proportion of the population who drink any alcohol is not increasing, there has been an increase in the prevalence of both heavy drinking (defined as more than 1 drink per day for women or 2 drinks per day for men, on average) and binge drinking (defined as at least 4 drinks for women or 5 for men in the last thirty days)\[[@B5]\]. Heavy drinking has been shown to increase the risk of ALD and all-cause mortality\[[@B6]\]. Because we have noticed a recent increase in the number of referrals to our transplant center for ALD, we decided to critically review the temporal and geographic trends in the LT for ALD and examine characteristics of patients transplanted for ALD.

MATERIALS AND METHODS
=====================

Data source
-----------

We conducted a retrospective cohort analysis of transplant recipients in the United Network for Organ Sharing (UNOS) Standard Transplant Analysis and Research file. United States donor data for this analysis is Organ Procurement and Transplantation Network data released 2016-06-17 based on data collected through 2016-03-31. UNOS as the contractor for the Organ Procurement and Transplantation Network supplied this data. The interpretation and reporting of these data are the responsibility of the authors and in no way should be seen as an official policy of or interpretation by the Organ Procurement and Transplantation Network or the United States Government. The statistical methods of this study were reviewed by Dr. James Perkins from the University of Washington. This study met expedited review criteria as approved by the University of Washington Institutional Review Board.

Study population and temporal trends
------------------------------------

We identified all liver transplant recipients in the UNOS database from 2002 to 2015 and characterized them according to the etiology of their liver disease. The category ALD was defined as recipients with a diagnosis of alcoholic cirrhosis or acute alcoholic hepatitis. However, in order to minimize the effect of concomitant liver disease, we categorized those with a listing diagnosis of both HCV and alcoholic cirrhosis (HCV/ALD) as HCV.

Recipient characteristics were compared among the leading four etiologies of cirrhosis using χ^2^ test for categorical values and student's *t*-test used for continuous variables. The number of transplants per year by liver disease was graphed to illustrate changes over time.

ALD subgroup analysis
---------------------

We performed a subgroup analysis of recipients transplanted for ALD. Temporal trends in recipient characteristics were studied and compared using χ^2^ test for categorical values and student's *t*-test used for continuous variables. We then used time series analysis to identify any year with a significant change in the number of transplants per year, and then compared transplant rates in the "before" and "after" eras. To model transplant growth in each era, we used a spline linear regression model with the cut point at the year predicted by the time series analysis.

To determine if age or gender had any affect on change in transplant rates, we also compared mean transplants per year in the before and after eras for categorical age groups (18-30, 31-40, 41-50, 51-60, 61-70 and 71-83 years old) and gender using student's *t*-test. We also used this method to evaluate the contribution of transplants for acute alcoholic hepatitis, separating the ALD population into acute alcoholic hepatitis from alcoholic cirrhosis subgroups. We hypothesized that the increasing use of curative treatment for HCV cirrhosis could lead to a change in the classification of cirrhosis etiology, such that patients previously listed as HCV/ALD were subsequently listed as alcoholic cirrhosis alone. Hence, we analyzed the change in time for the HCV/ALD population using the same approach as above.

Analysis of transplant changes by region
----------------------------------------

UNOS is an organization involved in many aspects of the organ transplant and donation process and operates by grouping states into several different regions throughout the country. To facilitate transplantation, the US is divided into 11 geographic regions. Liver transplant recipients were grouped by UNOS region and the mean number of transplants per region per year for the before and after eras was calculated.

Statistical analysis
--------------------

Analyses were conducted using JMP Pro 13.0.0 (SAS Institute Inc. Cary, NC) statistical software, graphics were made in Stata 12.1 (College Station, TX, United States).

RESULTS
=======

Study population
----------------

Of 74216 liver transplant recipients, ALD (*n =* 9400, 12.7%) was the third leading indication for transplant after HCV (*n =* 21707, 29.2%) and hepatocellular carcinoma (HCC) (*n =* 16627, 22.4%) (Figure [1A](#F1){ref-type="fig"}). Recipients with ALD were younger, more likely to be non-black and have a higher model for end-stage liver disease (MELD) at transplant than recipients with HCV, HCC or NASH cirrhosis (Table [1](#T1){ref-type="table"}). Time series analysis demonstrated a significant increase in the number of transplants for ALD starting in 2013 (*P =* 0.03) (Figure [1B](#F1){ref-type="fig"}).

###### 

Recipient characteristics by etiology of liver disease

                       **HCV** **21707 (29.2%)**   **HCC** **16627 (22.4%)**   **ALD** **9400 (12.7%)**   **NASH** **4745 (6.4%)**   ***P* value**
  -------------------- --------------------------- --------------------------- -------------------------- -------------------------- ---------------
  Age                  54.1 ± 7.19                 57.9 ± 7.8                  53.5 ± 9.02                56.7 ± 10.2                \< 0.001
  Female               5799 (26.7%)                3928 (23.6%)                2210 (23.5%)               2237 (47.1%)               \< 0.001
  Race                                                                                                                               \< 0.001
  White                15408 (71.0%)               11133 (67.0%)               7533 (80.1%)               4006 (84.4%)               
  Hispanic             3071 (14.2%)                2496 (15.0%)                1285 (13.7%)               524 (11%)                  
  Black                2504 (11.5%)                1542 (9.3%)                 371 (4.0%)                 95 (2%)                    
  Other                724 (3.3%)                  1456 (8.8%)                 211 (2.2%)                 120 (2.5%)                 
  BMI                  28.4 ± 5.3                  28.3 ± 5.3                  27.9 ± 5.41                32 ± 6.1                   \< 0.001
  Diabetes                                                                                                                           \< 0.001
  None                 16912 (77.9%)               11741 (70.6%)               7440 (79.2%)               2139 (45.1%)               
  Any                  4430 (20.4%)                4733 (28.5%)                1828 (19.5%)               2545 (53.6%)               
  Unknown              365 (1.7%)                  153 (0.9%)                  132 (1.4%)                 61 (1.3%)                  
  MELD at transplant   22 ± 10                     15 ± 8.3                    25.1 ± 9.6                 23.8 ± 9.2                 \< 0.001
  HCC in explant       3919 (18.1%)                11034 (66.4%)               482 (5.1%)                 260 (5.5%)                 \< 0.001

HCV: Hepatitis C virus; HCC: Hepatocellular carcinoma; ALD: Alcoholic liver disease; NASH: Non-alcoholic steatohepatitis; BMI: Body mass index.

![Time series analysis demonstrated a significant increase in the number of transplants for alcoholic liver disease starting in 2013. A: Number of transplants per year by etiology of liver disease; B: Time series analysis of alcoholic liver disease liver transplant recipients demonstrating a significant change in the number of transplants starting in 2013 (*P* = 0.03). ALD: Alcoholic liver disease; HCV: Hepatitis C virus; NASH: Non-alcoholic steatohepatitis; HCC: Hepatocellular carcinoma.](WJH-9-1315-g001){#F1}

ALD subgroup analysis
---------------------

The total number of transplants performed for ALD increased from 553 (12.8% of the annual total) in 2002 to 1020 (16.5%) in 2015 (Table [2](#T2){ref-type="table"}). Age and BMI remained unchanged over the study period, but there was a significant increase in the proportion of female recipients (from 22.4% in 2002 to 27.5% in 2015, *P =* 0.001) and an increase in MELD (20.6 ± 8.4 in 2002 to 28.9 ± 10.4 in 2015, *P* \< 0.001). In the before era, the number of transplants per year was stable as predicted by the linear spline model (coefficient 3.3, 95%CI: -4.6, 11.2). In the after era, there were approximately 177 more transplants per year for ALD (coefficient 176.7, 95%CI: 119.4, 234.0) (Figure [2](#F2){ref-type="fig"}).

###### 

Temporal trends in characteristics of alcoholic liver disease liver transplant recipients

                   **2002**      **2003**      **2004**      **2005**      **2006**      **2007**      **2008**      **2009**      **2010**      **2011**      **2012**      **2013**      **2014**      **2015**       **P value**
  ---------------- ------------- ------------- ------------- ------------- ------------- ------------- ------------- ------------- ------------- ------------- ------------- ------------- ------------- -------------- -------------
  *n* (% annual)   553 (12.8%)   597 (12.8%)   628 (12.4%)   688 (13.0%)   695 (12.7%)   660 (12.3%)   578 (11.1%)   608 (11.6%)   619 (11.7%)   651 (12.1%)   613 (11.4%)   685 (12.4%)   805 (13.9%)   1020 (16.5%)   
  Age              53.0 ± 8.2    52.9 ± 8.5    54.0 ± 8.8    53.4 ± 8.6    53.7 ± 8.6    54.5 ± 8.7    53.6 ± 8.9    54.3 ± 8.5    54.1 ± 8.9    54.0 ± 8.9    53.6 ± 8.9    52.8 ± 9.4    53.7 ± 9.7    52.5 ± 10.2    0.1
  Female           124 (22.4%)   126 (21.1%)   125 (19.9%)   134 (19.5%)   156 (22.4%)   133 (20.2%)   127 (22.0%)   146 (24.0%)   164 (26.5%)   170 (26.1%)   153 (25.0%)   172 (25.1%)   200 (24.8%)   280 (27.5%)    0.001
  Race                                                                                                                                                                                                                  0.03
  Black            15 (2.7%)     16 (2.7%)     23 (3.7%)     24 (3.5%)     32 (4.6%)     19 (2.9%)     21 (3.6%)     22 (3.6%)     18 (2.9%)     37 (5.7%)     23 (3.8%)     35 (5.1%)     38 (4.7%)     48 (4.7%)      
  Hispanic         71 (12.8%)    76 (12.7%)    76 (12.1%)    77 (11.2%)    98 (14.1%)    98 (14.8%)    95 (16.4%)    79 (13.0%)    85 (13.7%)    88 (13.5%)    93 (15.2%)    96 (14.0%)    103 (12.8%)   150 (14.7%)    
  Other            6 (1.1%)      12 (2.0%)     13 (2.1%)     12 (1.7%)     9 (1.3%)      12 (1.8%)     16 (2.8%)     9 (1.5%)      20 (3.2%)     16 (2.5%)     13 (2.1%)     18 (2.6%)     17 (2.1%)     38 (3.7%)      
  White            461 (83.4%)   493 (82.6%)   516 (82.2%)   575 (83.6%)   556 (80.0%)   531 (80.5%)   446 (77.2%)   498 (81.9%)   496 (80.1%)   510 (78.3%)   484 (79.0%)   536 (78.2%)   647 (80.4%)   784 (76.9%)    
  BMI              27.7 ± 5.3    27.8 ± 5.2    27.7 ± 5.5    27.9 ± 5.4    27.7 ± 5.4    28.4 ± 5.5    27.9 ± 5.4    27.9 ± 5.4    28.0 ± 5.6    27.9 ± 5.5    28.1 ± 5.4    28.0 ± 5.3    27.8 ± 5.4    28.0 ± 5.5     0.3
  Diabetes                                                                                                                                                                                                              \< 0.001
  None             433 (78.3%)   458 (76.7%)   493 (78.5%)   538 (78.2%)   548 (78.8%)   484 (73.3%)   440 (76.1%)   485 (79.8%)   487 (78.7%)   518 (79.6%)   509 (83.0%)   560 (81.8%)   659 (81.9%)   828 (81.2%)    
  Any              103 (18.6%)   122 (20.4%)   116 (18.5%)   138 (20.1%)   134 (19.3%)   167 (25.3%)   131 (22.7%)   109 (17.9%)   127 (20.5%)   128 (19.7%)   100 (16.3%)   122 (17.8%)   144 (17.9%)   187 (18.3%)    
  Unknown          17 (3.1%)     17 (2.8%)     19 (3.0%)     12 (1.7%)     13 (1.9%)     9 (1.4%)      7 (1.2%)      14 (2.3%)     5 (0.8%)      5 (0.8%)      4 (0.7%)      3 (0.4%)      2 (0.2%)      5 (0.5%)       
  MELD             20.6 ± 8.4    21.6 ± 9.2    22.6 ± 9.5    22.6 ± 8.7    22.8 ± 8.5    23.9 ± 8.9    24.8 ± 9.0    25.1 ± 8.7    25.8 ± 9.4    26.1 ± 9.5    27.0 ± 9.3    27.5 ± 9.7    28.1 ± 9.6    28.9 ± 10.4    \< 0.001
  HCC in explant   58 (10.5%)    41 (6.9%)     51 (8.1%)     37 (5.4%)     44 (6.3%)     39 (5.9%)     30 (5.2%)     23 (3.8%)     18 (2.9%)     27 (4.1%)     24 (3.9%)     28 (4.1%)     23 (2.9%)     39 (3.8%)      \< 0.001

BMI: Body mass index; HCC: Hepatocellular carcinoma.

![Linear spline fit for number of transplants for year for alcoholic liver disease in the before and after eras.](WJH-9-1315-g002){#F2}

All age groups except those 71-83 years old showed a significant increase in the mean number of transplants per year for ALD when comparing before and after eras, but the greatest proportional increase was seen in the youngest recipients (Table [3](#T3){ref-type="table"}). The proportional increase in mean transplants per year was greater in females than males, and was significant for both genders (*P =* 0.001, 0.005, respectively). Although there was a 1.4 fold increase in transplants for alcoholic hepatitis, this was not statistically significant (*P =* 0.58), only represented an increase of approximately 3 transplants per year, and did not explain the overall increase in transplants for ALD. As expected, there was a decrease in transplants for HCV/ALD, however this decrease (90.7 transplants per year) was much less than the per year increase for ALD (210.3 transplants per year).

###### 

Changes in number of transplants per year for alcoholic liver disease by age group, gender and etiology

                        **Mean per year 2002-2012**   **Mean per year 2013-2015**   **Difference**   **Change**   ***P* value**
  --------------------- ----------------------------- ----------------------------- ---------------- ------------ ---------------
  Total                 626.4                         836.7                         210.3            1.34         0.002
  Age group (yr)                                                                                                  
  18-30                 4.3                           14.3                          10.1             3.35         0.003
  31-40                 40.7                          84.0                          43.3             2.06         0.001
  41-50                 170.5                         219.7                         49.1             1.29         0.005
  51-60                 264.5                         314.3                         49.8             1.19         0.040
  61-70                 138.4                         195.0                         56.6             1.41         0.010
  71-83                 7.9                           9.3                           1.4              1.18         0.500
  Gender                                                                                                          
  Female                141.6                         217.3                         75.7             1.53         0.001
  Male                  484.7                         619.3                         134.6            1.28         0.005
  Etiology                                                                                                        
  Alcoholic cirrhosis   619.5                         827.0                         207.5            1.33         0.002
  Alcoholic hepatitis   6.8                           9.7                           2.8              1.42         0.580
  HCV/ALD               274.4                         183.7                         -90.7            0.67         0.050

HCV: Hepatitis C virus; ALD: Alcoholic liver disease.

Analysis of transplant and alcohol use by region
------------------------------------------------

All regions except region 9 saw an increase in the mean number of transplants per year when comparing eras, and this increase was significant in regions 2, 3, 4, 5, 6, 8, 10 and 11 (Table [4](#T4){ref-type="table"}, Figure [3](#F3){ref-type="fig"}).

![UNOS regions in the United States\[[@B29]\].](WJH-9-1315-g003){#F3}

###### 

Changes in number of transplants per year for alcoholic liver disease by UNOS region

  **UNOS region**   **Mean per year 2002-2012**   **Mean per year 2013-2015**   **Difference**   **Change**   ***P* value**
  ----------------- ----------------------------- ----------------------------- ---------------- ------------ ---------------
  1                 28.5                          37.3                          8.8              1.31         0.09
  2                 86.0                          120.3                         34.3             1.40         0.01
  3                 103.4                         142.7                         39.3             1.38         0.02
  4                 54.1                          75.7                          21.6             1.40         0.05
  5                 75.5                          117.3                         41.8             1.55         0.003
  6                 13.0                          24.7                          11.7             1.90         0.001
  7                 83.1                          89.0                          5.9              1.07         0.32
  8                 33.6                          52.3                          18.7             1.56         0.002
  9                 43.4                          28.3                          -15.0            0.65         0.23
  10                52.3                          71.0                          18.7             1.36         0.03
  11                53.5                          78.0                          24.5             1.46         0.005

DISCUSSION
==========

In a nationwide cohort of liver recipients, we found that the number of transplants for ALD was stable between 2002 and 2012, but rose by approximately 177 transplants per year between 2013 and 2015. This increase was observed more in young recipients and in females and was incompletely explained by a decrease in transplants for HCV/ALD. There was a significant increase in 8 out 11 UNOS regions, and a decrease only in region 9. This increase in transplants for ALD has not been previously described.

Prior epidemiologic studies on the indication for liver transplant have shown stable to decreasing rates of transplants for ALD, but these studies were based on data collected before 2013\[[@B7],[@B8]\]. However, a more recent study noted an increase in transplants for ALD in recent years, which is more rapid than that for NASH\[[@B9]\]. Population-based studies have shown an increase in heavy alcohol use\[[@B5]\], binge drinking\[[@B5]\] and per capita alcohol use\[[@B10]\] since the early 2000s. During the same time period, there was an increase in hospitalization for alcohol-related diagnosis and an increase in age-adjusted death rates from ALD\[[@B11],[@B12]\]. Furthermore, the proportion of cirrhosis-related deaths attributable to alcohol have increased in young patients (25-54 years old)\[[@B12]\]. However, other data suggest decreasing overall prevalence of ALD in the population\[[@B9]\].

The reason for this increase in transplants for ALD starting in 2013 is uncertain. Our data suggest that the surge is not due to an increasing BMI in this population or an increase in transplants for acute alcoholic hepatitis, and it is not solely due to reclassification of HCV/ALD transplants as ALD. There has been a steady increase in the number of new waitlistings for ALD, but the rate of rise of transplants since 2013 seems to exceed the rate of rise of listings\[[@B9]\]. Perhaps there has been a recent improvement in both the referral for transplant and wait-listing for patients with ALD, who have historically have lower rates of both referral\[[@B13],[@B14]\] and waitlist\[[@B15]\]. The American Association for the Study of Liver disease revised the "Evaluation for Liver Transplantation in Adults Practice Guidelines" in 2005\[[@B16]\] and again 2013\[[@B17]\]. The 2005 Guidelines recommended "it is prudent to delay transplantation for a minimum of 3-6 mo of abstinence from alcohol." However, in the 2013 guidelines it was acknowledged that 6 mo of sobriety before referral "may result in deterioration of the patient's medical condition so that psychosocial or addiction requirements determined from the initial evaluation may not be achievable." While there is not a temporal relationship between this publication (March 2014) and our observed increased in transplants for ALD (start of 2013), the 2013 Guidelines may reflect a developing leniency of the abstinence requirement amongst transplant programs.

ALD is historically the second most common etiology for LT in the European Liver Transplant Registry at 33.6%, trailing only virus related cirrhosis. However, in the setting of treatment for HCV, ALD has become the leading indication for LT\[[@B18]\]. There has been a sustained increase in the proportion of transplants performed for ALD since the late-1980s, including 2013-2015. In a Nordic paper, the proportion of transplants for ALD remained relatively constant between 1994 and 2013\[[@B19]\].

Early identification of problematic alcohol use and reduction in drinking has the potential to change the pattern we have described. Only 10% of patients with drinking problems are identified by primary care providers, and under-diagnosis is common in teenagers\[[@B20]\]. Brief interventions in the primary care setting can result in reduced consumption and may subsequently reduce alcohol-related harm and mortality\[[@B21],[@B22]\]. After a single course of treatment by a qualified alcohol counselor, abstinent rates are 17 to 33% and an additional 7% to 12% reduce their intake\[[@B23]\].

There are several simple screening tools for alcohol use that are designed to be highly sensitive and easy to use in the primary care setting. The CAGE questionnaire is a 4-question test with binary answers; two "yes" responses are considered a positive test and should prompt additional testing\[[@B24],[@B25]\]. Alternatively, the more extensive alcohol use disorders identification test was developed by the World Health Organization and consists of ten questions with five possible answers and a focus on identification of heavy drinkers\[[@B26],[@B27]\]. Another option is a single screening question "How many times in the past year have you had 5 (males) or 4 (females) or more drinks in a day?" with a cutoff of 8 times, and can also be used to accurately identify patients with unhealthy alcohol use with good discrimination\[[@B28]\]. The widespread use of electronic medical records make systematic implementation of well validated tools inexpensive and quite practical. This would follow the approach for identification of smoking using the electronic medical record. The potential for this approach on the prognosis of patients with ALD could be profound.

There were several limitations to our study. We examined only patients transplanted for ALD, not those listed for transplantation, so we are unable to determine whether the increase observed is due to an increasing listing for ALD or an increase in the proportion of waitlisted patients with ALD undergoing transplant. However, Goldberg et al\[[@B29]\] recently showed a steeper rate of rise for LTs for ALD than absolute number of new waitlistings, although both are increasing. Additionally, we were unable to further explore why all but three UNOS regions demonstrated an increase in transplants for ALD.

In conclusion, in this study we demonstrate a nationwide increase in the number of transplants per year for ALD beginning in 2013, particularly in young and female patients. The reason for this increase is unknown, but comes in the setting of widespread and increasing alcohol use and hospital admissions for ALD. Consideration should be given to the use of screening tools aimed at detecting alcohol use in the primary care setting to identify patients with problematic alcohol use and promote reduction in consumption in order to avoid harm.
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